Fix the NHS or miss out on our money, US drug giant warns Britain
Sir Keir Starmer must urgently address problems with the NHS or risk missing out on future investment in Britain, the UK boss ...
Xeris Biopharma: Low Risk, Low Excitement Solid Revenue Generator
Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...
Jim Cramer Says: “Keep an Eye on Eli Lilly and Company (LLY)”
We recently published a list of Jim Cramer Discusses These 10 Stocks & Says Trump Should Carry A Howitzer And Be Soft. In ...
Slow NHS puts investment at risk, warns ‘King Kong’ weight-loss jab maker
Sir Keir Starmer must urgently address problems with the NHS or risk missing out on future investment in Britain, the UK boss ...
pharmaphorum23h
AbbVie, Lilly pull out of UK voluntary drug pricing agreement
AbbVie and Eli Lilly have left the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), according to an update issued this morning by the Association of the British Pharmaceutical ...
Sky19h
A new drug is causing horror on US streets
One person dies of a drug overdose every five minutes in America. More than 70,000 people a year are already being killed by the opioid Fentanyl. This drug is now being mixed with something even ...
pharmaphorum23h
Alnylam grabs FDA approval for its second amyloidosis therapy
Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...